HomeAmgen

  • Novartis wins Aimovig approval for launch in the EU markets

    • August 3, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Aimovig for Migraine receives positive CHMP opinion by EMA, might get approved soon in EU

    • June 2, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • FDA approves Aimovig, first aCGRP drug for preventive treatment of Migraine

    • May 18, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more